 |
|
|
[ send your article ] ArticlesMore articles: [newest], [05], [04], [03], [02], [01] One in six men today will be diagnosed with prostate cancer, now the most common type of cancer next to skin cancer. But is there anything men can do to lower their risk of getting prostate cancer? The answer is "yes" and "no." [ read full article ] A team that reviewed early stage prostate-cancer cases from the Surveillance, Epidemiology and End Results (SEER)-Medicare database.has revealed that short-term and long-term costs of prostate cancer care vary considerably based on which treatment strategy a man initially receives. [ read full article ] Surgery and transurethral treatments, radiation therapies and prostate medicines are effective but they also have side effects. In many cases the condition reoccurs after treatment. It is imperative that you tackle the issue of prostate health proactively and ensure that you take a certain number of preventive measures. [ read full article ] All treatments for prostate cancer run the risk of creating erectile dysfunction, impotence. Surgery is a risk because a bundle of nerves and blood vessels is on either side of the prostate, in close proximity to the gland. Those nerves and bundles fill the penis with blood for sexual relations... [ read full article ] In a newly published report, a team of clinicians from Columbia University Medical Center has provided data on the 10-year follow-up of a small group of patients treated with salvage or primary cryotherapy for prostate cancer. Clinicians claim that this is the longest reported follow-up on patients treated with cryotherapy ... [ read full article ] According to a large-scale study from Sweden, for patients with prostate cancer that has a low risk of development, watchful waiting, also known as "active surveillance," may be a suitable treatment option. [ read full article ] First of all you should learn that LESS stands for laparo-endoscopic single-site surgery. In simple words, LESS is laparoscopic surgery through one small abdominal incision (a “port”) as opposed to the five or six that are currently used. [ read full article ] Johns Hopkins experts have found that men enrolled in an active surveillance program for prostate cancer that eventually needed surgery to remove their prostates fared just as well as men who opted to remove the gland immediately, except if a follow-up biopsy during surveillance showed high-grade cancer. [ read full article ] A new study at University of Michigan reveals.the main cause of prostate cancer could be the fusion of two genes and the subsequent abnormal prostate cell growth that results when receptors for the hormone androgen get blocked. Researchers suggest the implication is that standard efforts to treat the disease ... [ read full article ] For many men worldwide, prostate cancer treatment often leaves them with the potential of being impotent and the potential of incontinency, but a new procedure is producing the same results without the side effects. [ read full article ] Prostate cancer is a complicated condition, and researchers are working hard to understand its causes. For a long time now doctors have known that prostate cancer "runs in the family". Several studies have identified prostate cancer family history as an elevated risk factor for prostate cancer incidence. [ read full article ] It was demonstrated that prostate tumors need testosterone to grow. By consequence, one treatment involves castration to combat the body's processing of testosterone, possibly with additional drug treatment. [ read full article ] With the rapid ageing of the population and the exponential increase of life-expectancy in developed countries, experts expect that the burden of prostate cancer to rise up dramatically in the future. The problem is, to date, no specific guidelines on the management of prostate cancer in older men have been published. [ read full article ] According to a new study, despite the popularity of robot-assisted procedures for prostate cancer, when it comes to men's long-term quality of life, patients with earlier stage cancers generally fare better with non-surgical approaches than with surgery. [ read full article ] Prostate cancer is the most common diagnosed cancer in men. It is a fact tha death rates from this cancer have decreased since 1995, but some risk factors can still raise your chances of getting the disease. [ read full article ] Undoubtedly, prostate specific antigen (PSA) testing and prostate cancer treatment saves lives. However, there are growing concerns regarding overtreatment. There has also been a shift toward less invasive approaches to prostate cancer, including cryotherapy. [ read full article ] Active surveillance, also referred to as watchful waiting, is a viable option for many men with low risk prostate cancer although the concept continues to cause distress and confusion. [ read full article ] Researchers at Stanford University (California, USA) and Aarhus University Hospital (Aarhus, Denmark), partially supported by Varian Medical Systems (NYSE: VAR), have made a breakthrough in image-guided targeting of prostate tumors during arc radiotherapy treatments. [ read full article ] The new American Cancer Society (ACS) issued updated screening guidelines provide detailed advice on the kind of information that should be discussed regarding the pros and cons of the screening tests. [ read full article ] Basically, localized prostate cancer treatment falls into one of two general categories: (a) kill or surgically prostate removal (and prostate cancer) cells in the patient or (b) monitor (by active surveillance) the patient until he needs hormone therapy (with the hope that he never does). [ read full article ] According to a science advisory published in Circulation: Journal of the American Heart Association, (AHA) androgen-deprivation therapy (ADT), commonly used to treat prostate cancer, can worsen heart risk factors and may increase the risk of heart attack and/or cardiac death. [ read full article ] According to a group of researchers at Queen’s University in Kingston, Ontario, a very low dose of nitroglycerin may be able to delay the progression of prostate cancer in men with a rising PSA after standard first-line treatment with radiotherapy or surgery. [ read full article ] One of the most concerning problem for patients in the treatment of prostate cancer is erectile dysfunction. The inconsistent evaluation of sexual function (SF) and limited follow-up data request additional study to clarify the rate and timing of erectile dysfunction after external beam radiotherapy (EBRT) for prostate cancer. [ read full article ] A recent study at Department of Urology and Andrology, CHU Reims, Reims, France, aimed to report on technical incidents and early and late complications occurring in high-intensity focused ultrasound (HIFU) treatment of patients with localized prostate cancer. [ read full article ] A new study at Sutter Roseville Medical Center, Roseville, CA, USA, aimed to evaluate the percentages of men with and without changes in sexual function from the beginning to end of radiation therapy. The study also evaluated differences in demographic and clinical characteristics, ... [ read full article ] A recent study at Memorial Sloan-Kettering Cancer Center revealed that inexperienced surgeons treat many prostate cancer patients in United States. This lack of high-volume experience induces increased complications such as incontinence and impotence, and possible cancer recurrence. [ read full article ] The updated NCCN clinical guidelines for prostate cancer now include an explicit recommendation for active surveillance (watchful waiting) and only active surveillance for many men diagnosed with prostate cancer. [ read full article ] More articles: [newest], [05], [04], [03], [02], [01] [ send your article ] NOTE: Issues on this site regarding prostate cancer and treatment options, are provided for information only, and are not meant to substitute for the advice of your own physician or other medical professional. Prostate-Report.org does not endorse any specific product, service or treatment. |
|